Alan Saghatelian, PhD - Salk Institute for Biological Studies

Por um escritor misterioso
Last updated 20 fevereiro 2025
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Alan Saghatelian
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Exo Therapeutics raises $78 million to target enzyme exosites with
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Scientists find 'outlier' enzymes, potential
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Seminar: Alan Saghatelian, PhD – Molecular Biology Institute
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Alan Saghatelian
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Making Microprotein Discoveries With Alan Saghatelian – Biomedical
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Inspiring Collaboration in Cancer Research: The Mark Foundation
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Making Microprotein Discoveries With Alan Saghatelian – Biomedical
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Keypoint Newsletter: Introducing the New Fellows Class of 2022
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Salk Institute (@salkinstitute) / X
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Novartis-backed Exo Therapeutics secures $78M to reprogram enzymes
Alan Saghatelian, PhD - Salk Institute for Biological Studies
Small protein connected to Alzheimer's risk

© 2014-2025 likytut.eu. All rights reserved.